Lab21 acquires molecular diagnostics company Myconostica Ltd
Lab21 Limited has announced that it has acquired Myconostica Ltd. The financial terms of the deal were not disclosed. The acquisition of Myconostica expands Lab21’s growing proprietary diagnostic portfolio and will provide the Company’s first set of nucleic acid-based assays. Furthermore it will provide manufacturing capabilities for Lab21 from which it will develop and produce its range of new biomarker assays.
There is a major unmet market need for diagnosis of life threatening invasive fungal disease and the Myconostica products are leaders in this market. Current fungal diagnostic tests based on culturing techniques have significant clinical limitations and Myconostica’s molecular diagnostic approach provides more rapid, sensitive and specific information which will improve clinical outcomes. In addition to developing global sales of Myconostica products, Lab21 will also be launching the Myconostica fungal testing services from its new reference laboratory in South Carolina as well as its laboratory in Cambridge, UK.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
Cryo-imaging lifts the lid on fuel cell catalyst layers - First insights into the nanostructure of platinum catalyst layers
JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
Ring of complex organic molecules around newborn star discovered
Researchers discover new genetic mutation that causes male infertility
Exonhit presents new opportunities in blood diagnostics in neurodegenerative diseases - Identification of new markers for BSE in collaboration with Roche Applied Science
Wanted: The faces of the chemical crowd